Tables
Stages of GOLD 2010 SABD LABD IC Methylxanthines Mucolytic agents IF-4 At diagnosis I 58% 71% 22% 0 16% 0 II 69% 64% 44% 5% 26% 0 III 77% 70% 55% 19% 37% 3% IV 77% 65% 54% 27% 35% 0 Unknown 39% 38% 26% 5% 16% 1% At present I 33% 96% 37% 0 37% 1% II 44% 93% 52% 6% 26% 9% III 58% 95% 75% 10% 34% 18% IV 64% 96% 89% 21% 39% 29% Unknown 40% 84% 49% 5% 27% 9% SABD: Short-acting bronchodilators; LABD: Long-acting bronchodilators, CI: Inhaled glucocorticoids; IF-4: inhibitor of the enzyme PDE-4
Vol 44 Issue Suppl 58
Table of Contents
Pharmacological treatment of COPD in the on-sint cohort
